GLP1R agonists: primary cardiovascular prevention and oral administration.

Nat Rev Cardiol · 2019

Last updated 2026-05-28

Journal	Nat Rev Cardiol, 2019
Citations	2
Relative citation ratio	0.07
NIH percentile	6
Molecules	—
Conditions studied	Cardiovascular Risk Reduction

Full record and abstract on PubMed 31239524 ↗